Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

2.
3.
4.
5.

A G/C element mediates repression of the SM22alpha promoter within phenotypically modulated smooth muscle cells in experimental atherosclerosis.

Wamhoff BR, Hoofnagle MH, Burns A, Sinha S, McDonald OG, Owens GK.

Circ Res. 2004 Nov 12;95(10):981-8. Epub 2004 Oct 14.

6.

Binding of serum response factor to CArG box sequences is necessary but not sufficient to restrict gene expression to arterial smooth muscle cells.

Strobeck M, Kim S, Zhang JC, Clendenin C, Du KL, Parmacek MS.

J Biol Chem. 2001 May 11;276(19):16418-24. Epub 2001 Feb 8.

7.

Smooth muscle cells and myofibroblasts use distinct transcriptional mechanisms for smooth muscle alpha-actin expression.

Gan Q, Yoshida T, Li J, Owens GK.

Circ Res. 2007 Oct 26;101(9):883-92. Epub 2007 Sep 6.

8.

Analysis of SM22alpha-deficient mice reveals unanticipated insights into smooth muscle cell differentiation and function.

Zhang JC, Kim S, Helmke BP, Yu WW, Du KL, Lu MM, Strobeck M, Yu Q, Parmacek MS.

Mol Cell Biol. 2001 Feb;21(4):1336-44.

9.

The SM 22 promoter directs tissue-specific expression in arterial but not in venous or visceral smooth muscle cells in transgenic mice.

Moessler H, Mericskay M, Li Z, Nagl S, Paulin D, Small JV.

Development. 1996 Aug;122(8):2415-25.

10.

An overlapping CArG/octamer element is required for regulation of desmin gene transcription in arterial smooth muscle cells.

Mericskay M, Parlakian A, Porteu A, Dandré F, Bonnet J, Paulin D, Li Z.

Dev Biol. 2000 Oct 15;226(2):192-208.

11.

Expression of the smooth muscle cell calponin gene marks the early cardiac and smooth muscle cell lineages during mouse embryogenesis.

Miano JM, Olson EN.

J Biol Chem. 1996 Mar 22;271(12):7095-103. Erratum in: J Biol Chem 1997 Oct 24;272(43):27492.

12.
13.

Human SM22 alpha BAC encompasses regulatory sequences for expression in vascular and visceral smooth muscles at fetal and adult stages.

Xu R, Ho YS, Ritchie RP, Li L.

Am J Physiol Heart Circ Physiol. 2003 Apr;284(4):H1398-407. Epub 2003 Jan 9.

14.

Transcriptional targeting of replication-defective adenovirus transgene expression to smooth muscle cells in vivo.

Kim S, Lin H, Barr E, Chu L, Leiden JM, Parmacek MS.

J Clin Invest. 1997 Sep 1;100(5):1006-14.

16.

Cooperative binding of KLF4, pELK-1, and HDAC2 to a G/C repressor element in the SM22α promoter mediates transcriptional silencing during SMC phenotypic switching in vivo.

Salmon M, Gomez D, Greene E, Shankman L, Owens GK.

Circ Res. 2012 Aug 31;111(6):685-96. doi: 10.1161/CIRCRESAHA.112.269811. Epub 2012 Jul 18.

19.

HRC is a direct transcriptional target of MEF2 during cardiac, skeletal, and arterial smooth muscle development in vivo.

Anderson JP, Dodou E, Heidt AB, De Val SJ, Jaehnig EJ, Greene SB, Olson EN, Black BL.

Mol Cell Biol. 2004 May;24(9):3757-68.

20.

Vascular smooth muscle cell Smad4 gene is important for mouse vascular development.

Mao X, Debenedittis P, Sun Y, Chen J, Yuan K, Jiao K, Chen Y.

Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2171-7. doi: 10.1161/ATVBAHA.112.253872. Epub 2012 Jul 5.

Supplemental Content

Support Center